Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Enough said is correct. Numbers don't lie.
As you said pal, I'll take the double and run ..
This doesn't need to be a home run...
Based on what? Certainly not earnings, I bought and apparently watching volume I am not alone in the incredible value I see...
Please explain your reasoning with facts?
Hey Pete, yeah those 2 spuds been producing for a bit as well. With oil over $100 this should be a good value play. I'm in!
Hey iceman! Good to see you here. I started in the low-mid $.60's but adding on any dips. This has the markings of another GNUS or value-wise FRAN. She was over $2 in a July!
Now with the cap off elective surgeries and EU opening up with the US....sky's the limit!
I just snuck a few more this AM on low ball...
Back at 'cha!
This dog will run! Good morning, guy!
Support is good...a breakout even better. I've ridden this a couple times and made money everytime got q bunch of free shares...GLTA!
tdeck,
long time no see, dude! Since what, NGL or GNUS and some of the 'oldies, but goodies'...lol!
Cursory look finds I'll get some shares for sure. With Europe and the world opening back up this could be a barn burner!
Thanks for the heads-up...AGAIN!
Yeah, as we discussed I got some more today as well. I like the way this is shaping up as well...might have to see about a little more tomorrow.
Thanks to tdeck as well..
Others here hope so too..just sayn'
...long pipeline!
tdeck, I am one that benefited from your counsel.
If he's lyin' I'm dyin'!
Thanks, let's do it again!
Thanks for the update. Still watching and waiting here as well
tdeck, thanks for the update for INVESTORS. I capitalized because you are right they probably should go back to the FOMX symbol, that investors know although I am sure that must be against some law by SEC or another regulatory body.
I hold many shares, for me at least, but also believe that investors will be rewarded in a few months as the pipeline will blossom for the patient.
Thanks for keeping us up to date.
Totally different kinds of books, but I understand the increase in sales for COVID-19 lockdown for sure.
I'm a reader, but I have read 5 books in less than a month due in part to that fact. A couple Bill O'Reilly history, Clive Cussler, and Ted Bell.
The numbers should be sweet for Llama Llama #6 on NYT bestseller list can't wait!
Thanks for the update! Time is the needed commodity.
Exactly!
Genius Brands International Chairman & CEO Andy Heyward to Host Conference Call This Friday Discussing Rapid Growth in Broadcasting and Roll-Out of Merchandising Strategy around Llama Llama and Rainbow Rangers
11:00 am ET March 18, 2020 (Globe Newswire) Print
Genius Brands International, Inc. ("Genius Brands" or the "Company") (Nasdaq: GNUS), a global brand management company that creates and licenses multimedia entertainment content for children, today announced that it will host a business update conference call at 11:00 AM Eastern Time on Friday, March 20, 2020. Management will discuss the growth in broadcasting and roll-out of its merchandising strategy around the Company's tentpole children's shows, Netflix's Llama Llama and Rainbow Rangers on Nick Jr., as well as provide an update on the planned launch of Stan Lee's Super Kindergarten, starring Arnold Schwarzenegger, and the impact of the coronavirus on children's content viewing, and Genius Brands' shows in particular.
The conference call will be available via telephone by dialing toll free 800-935-9149 for U.S. callers or +1 862-298-0712 for international callers, or on the Company's News and Investors section of the website: https://ir.gnusbrands.com/.
A webcast replay will be available on the Company's News and Investors section of the website (https://ir.gnusbrands.com/) through March 20, 2021. A telephone replay of the call will be available approximately one hour following the call, through April 3, 2020, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering passcode: 33748.
About Genius Brands International
Genius Brands International, Inc. (Nasdaq: GNUS) is a leading global kids media company developing, producing, marketing and licensing branded children's entertainment properties and consumer products for media and retail distribution. The Company's award-winning 'content with a purpose' portfolio includes Stan Lee's Superhero Kindergarten, starring Arnold Schwarzenegger; Rainbow Rangers for Nick Jr.; Llama Llama, starring Jennifer Garner, for Netflix; award-winning toddler brand Baby Genius; adventure comedy STEM series Thomas Edison's Secret Lab; entrepreneurship series Warren Buffett's Secret Millionaires Club; and Stan Lee's Cosmic Crusaders, created with Stan Lee's Pow! Entertainment. Through licensing agreements with leading partners, characters from Genius Brands' IP also appear on a wide range of consumer products for the worldwide retail marketplace. The Company's Genius Brands Network of channels, including Kid Genius Cartoon Channel, Baby Genius TV, and Kid Genius Cartoons Plus!, are available in over 100 million U.S. television households via a multitude of distribution platforms, including Comcast, Cox, DISH, Amazon Prime, Sling TV, Apple TV, Roku, Amazon Fire and more. For additional information, please visit www.gnusbrands.com.
Left out the forward looking statements...
I echo the appreciation for tdeck's savy DD.
Now the only question is when does "John Q Public" or the retail investor figure out what we already know?
Thoughts?
Swampy, I'm with you! I don't NEED confirmation when it comes to sales and new products.
The numbers will tell us that when they come out....by then, it's too late to buy when its public knowledge. It's called risk assessment and I am fine with the 'risk'.
RyGuy I applaud you for your e-mail attempts to get a response.
Anymore, the corporations have to be so careful it is not surprising to get no response.
I too was frustrated, but tdeck's DD was so compelling I continued to add and am glad I did. These things always take longer than we like, but DD will prove out. This is just the beginning so hang on!
JS & pete, from the movie "Apocalypse"
'I love the smell of napalm in the morning!'...no that's the smell of shorts goin' up in flames!
This maybe the first but it is NOT the last. Get out the popcorn and Cokes and watch the show!
This was $20 - $30 about a year ago.
Freakin' Boo Ya!
About time this will be a rocket it was $20 - $30 few years ago...and it will return making us all VERY happy!
Agree. Too many bigger fish in this already maturing '5 year plan' previously announced by the founder.
UNLESS, they are using part of their increased revenues and profits to 'buy-back' these very cheap shares of their own stock?
A rhetorical question...
Johnsamuel, you got it!
Under expect and they over deliver
It will all be apparent soon.
RyGuy, I understand your frustration with being underwater on this stock. I am down about 30% on my investment. And, since it is one of my larger commitments we are talking major money here.
But also remember that you never 'lose' until you sell. You have lost nothing so far without selling. Not to say it isn't painful, but no loss, as such.
I expect when the numbers are finally released it will respond much as FRAN did for those that were around for that. It was a 5 bagger for me. This should be at least a triple or better.
All in my humble opinion and not to be confused as investment advice. Please all do your own due diligence.
Good point Pete, mine are up for $23 as well!
Tick Tock,...
Important Notice Regarding the Availability of Proxy Materials
for the Shareholder Meeting
2020 FOAMIX PHARMACEUTICALS LTD Special Meeting of Stockholders
MEETING DATE: February 6, 2020
For Holders as of: January 6, 2020
CUSIP NUMBER: M46135105
I agree pete807, as you know. If I had more dry powder to allocate there I would (or will, if it drops more..)
I am already heavily invested here, but would commit more money if it drops further.
Been a long haul but will be WELL worth it being in this early. We will be handsomely rewarded soon.
RyGuy, Sweet!
Great understandable stats! Now can't wait to see the next ER figures.
Want to see a FRAN-like rocket repeat for everybody here.
GLTA!
Now we are under $10, I'd rather see some $20's before moving up to next CC/ER to unload a few and keep a larger core.
If anybody is aware of it, he would be the man.
Acquired is one way to go, I would rather see the process and product line expand and improve BEFORE that happens. Better for shareholders too!
He'll probably give me grief for our 'mutual admiration society' but I agree.
He has a unique ability to cut through all the crap and read a bottom line on a stock/company better than anyone else I've seen.
I've been around and doing investments for over 50 years (sometimes not very well..) and he has a knack for sure. I like to listen and learn.
Great wrap up on the company! I think you've been taking lessons from tdeck...lol.
We do need a poison pill like FRAN did do we don't get bought out too soon and too cheap.
I am pleased and hope people continue to ignore this value as I will be buying more at their expense!
GLTA!
Likewise, Rookie2019, I am in for the long haul as well, as are my compadres. I own more than a few shares, this is a major holding for me. It is already a double as I am in around $.26 cost basis.
The trend should be up from here as the next Q will tell the tale without the drag of DB's 500 stores.
tdeck is right 'on the money'. What makes these so attractive to the hedge funds is that they already have a 73.1% return on it now....you think they aren't buying more on these downward fluctuations? Hardly..
GLTA!
Wrinkles, Got some more myself @ .40 on an old GTC order.
I am happy there or under. Original CB was $.259 so averaging up a bit.
Hell's bells! I bought it at $14.60, sold for $19.50 this is like shooting fish in a barrel.
Thanks tdeck, for the rod, reel, and fishing lessons!
GLTA!
So far had Mattel and Robinhood CEO's on. No sign of Mike so far.
Oops here's Mike Perry!
ASX/News Release
AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz Medical Campus Enter into Collaboration to Explore Potential Spray-On Treatment of Genetically Modified Cells for Epidermolysis Bullosa
AVITA Medical secures option for exclusive licensing of emerging technologies
Preclinical research will pair AVITA Medical’s Spray-On Skin™ Cells technology and expertise with the Gates Center’s patent pending combined reprogramming and gene editing methodology
Valencia, Calif., USA, Melbourne, Australia, and Aurora, Colo., USA, 25 November 2019 — AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the Gates Center for Regenerative Medicine at the University of Colorado School of Medicine announced today a preclinical research collaboration to establish proof-of-concept and explore further development of a spray-on treatment of genetically modified cells for patients with epidermolysis bullosa (EB), with potential applicability to other genetic skin disorders.
The partnership will pair AVITA Medical’s patented and proprietary Spray-On Skin™ Cells technology and expertise with the Gates Center’s innovative, patent pending combined reprogramming and gene editing technology to allow cells to function properly. Under the terms of the Sponsored Research Agreement (SRA), AVITA Medical retains the option to exclusively license technologies emerging from the partnership for further development and commercialization. The Gates Center team is further supported by the EB Research Partnership in New York, the Los Angeles-based EB Medical Research Foundation, the London-based Cure EB Charity and government grants, in a collaborative effort to rapidly develop and translate this technology to the clinic for meaningful impact on patient lives.
“The Gates Center is a leader in developing therapeutic approaches for genetic skin diseases. Researchers at the Gates Center have developed a powerful new approach for treating genetic skin disorders and improving the lives of patients with epidermolysis bullosa,” said Dr. Mike Perry, Chief Executive Officer of AVITA Medical and adjunct professor at the Gates Center for Regenerative Medicine. “We look forward to collaborating with the team at the Gates Center on the expanded use of our technology. This agreement marks an important milestone in AVITA’s mission to harness the potential of regenerative medicine to address unmet medical needs across a broad range of dermatological indications, including genetic disorders of the skin.”
Epidermolysis bullosa is a group of rare and incurable skin disorders caused by mutations in genes encoding structural proteins resulting in skin fragility and blistering, leading to chronic wounds and, in some sub-types, an increased risk of squamous cell carcinoma or death. There are no approved curative therapies, and current treatment is palliative - focused primarily on pain and nutritional management, itching relief, wound care, and bandaging.
“It’s very exciting to partner with AVITA Medical to help advance our epidermolysis bullosa program,” said Director of the Gates Center for Regenerative Medicine Dr. Dennis Roop. “We’re looking forward to exploring a novel approach to delivering gene-edited skin cells to patients that addresses current treatment challenges.”
“We believe that Spray-On Skin™ Cells technology combined with our genetically corrected cells has the potential to be game changing in the treatment of this disease. This combination could reduce time to treatment, lower manufacturing complexity, reduce costs and improve patient outcomes,” said Dr. Ganna Bilousova, assistant professor of dermatology, who is a co-principal investigator on this research program.